Chelation Therapy Fails to Improve Outcome in Heart Disease: The TACT2 Trial : Joel Kahn, MD: Integrative Cardiologist
In the TACT2 trial, chelation therapy reduced levels of lead in the blood but did not improve cardiovascular outcomes for adults with diabetes and a prior heart